| Kautilya Puri, MD | |
|
1762 Central Ave, 2 Floor, Suite # 202, Albany, NY 12205-4773 | |
| (518) 389-1310 | |
| (518) 464-8918 |
| Full Name | Kautilya Puri |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 1762 Central Ave, Albany, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053612440 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 217675 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kautilya Puri, MD 1762 Central Ave, 2 Floor, Suite # 202, Albany, NY 12205-4773 Ph: (518) 389-1310 | Kautilya Puri, MD 1762 Central Ave, 2 Floor, Suite # 202, Albany, NY 12205-4773 Ph: (518) 389-1310 |
News Archive
An alarming new article in Respirology issues a serious warning of massive rises in deaths from asbestos-related lung diseases in Asia. Dr Ken Takahashi, Acting Director of the WHO Collaborating Center for Occupational Health, and his team put together important data on asbestos use in 47 Asian countries in this landmark article. Cyprus, Israel and Japan had the highest age-adjusted mortality rates in Asia.
In celebration of National Nurses Week, EvergreenHealth recently recognized the exceptional care its nursing teams across the organization provide to enrich the health and well-being of each life they touch with the organization's annual Nursing Excellence awards. The organization awarded a group of exemplary caregivers during its nursing awards ceremony on May 8, 2012.
Novelos Therapeutics, Inc., a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the 725th event (patient death) has been reached in its pivotal Phase 3 trial in advanced non-small cell lung cancer (NSCLC) studying its lead product, NOV-002, in combination with first-line chemotherapy.
Galapagos NV (Euronext: GLPG), Charley's Fund Inc. and the Nash Avery Foundation announced today that they will collaborate to investigate the potential effectiveness of Galapagos' SARM candidate drug, G100192, in treating Duchenne muscular dystrophy. G100192 is an orally-available small molecule therapeutic, which has demonstrated successful Proof of Concept in pre-clinical studies for cachexia (the loss of weight and muscle mass).
In its official annual report, the President's Cancer Panel is recommending that people use home filtering devices to decrease exposure to cancer-causing agents.
› Verified 1 days ago
Arunima Rajbhandary, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-525-1550 | |
Dr. Rahul Ravilla, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 43 New Scotland Ave Ste 7, Albany, NY 12208 Phone: 518-262-6696 Fax: 518-262-2624 | |
Emmanuelle Cordero Torres, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave Dept Of Nephrology, Albany Medical Center, Albany, NY 12208 Phone: 518-262-5377 | |
Nancy Shrestha, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 5 Palisades Dr Ste 200, Albany, NY 12205 Phone: 518-471-3636 Fax: 518-471-3668 | |
Stephen Hillinger, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 400 Patroon Creek Blvd, Suite 1, Albany, NY 12206 Phone: 518-489-0044 Fax: 518-489-3591 | |
Louis H Gold, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5 Palisades Dr, Ste100, Albany, NY 12205 Phone: 518-438-4496 | |
Sean Joseph Sheehan, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1375 Washington Ave, Suite 101, Albany, NY 12206 Phone: 518-438-4483 Fax: 518-482-4201 |